Health
SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 – Aju Business Daily
[Courtesy of SK Bioscience]SEOUL — SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on…
[Courtesy of SK Bioscience]
SEOUL — SK Bioscience, a cooperation partner for South Korea’s state project to develop COVID-19 vaccines, will immediately embark on the first phase of clinical trials to evaluate the safety and immunogenicity of its vaccine candidate called NBP2001. The first test will be conducted on healthy adults at a state-run hospital.The Ministry of Food and Drug Safety said that SK Bioscience has been allowed to carry out clinical trials of NBP2001, a recombinant vaccine manufactured…
-
Noosa News14 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General15 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News17 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General13 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call